PITAVASTATIN MAGNESIUM
| Brand name | ZYPITAMAG |
|---|---|
| Active ingredient | PITAVASTATIN MAGNESIUM |
| Strength | EQ 1MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2017 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8829186 | January 2031 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.